Platelets amplify endotheliopathy in COVID-19
Open Access
- 10 September 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (37)
- https://doi.org/10.1126/sciadv.abh2434
Abstract
Given the evidence for a hyperactive platelet phenotype in COVID-19, we investigated effector cell properties of COVID-19 platelets on endothelial cells (ECs). Integration of EC and platelet RNA sequencing revealed that platelet-released factors in COVID-19 promote an inflammatory hypercoagulable endotheliopathy. We identified S100A8 and S100A9 as transcripts enriched in COVID-19 platelets and were induced by megakaryocyte infection with SARS-CoV-2. Consistent with increased gene expression, the heterodimer protein product of S100A8/A9, myeloid-related protein (MRP) 8/14, was released to a greater extent by platelets from COVID-19 patients relative to controls. We demonstrate that platelet-derived MRP8/14 activates ECs, promotes an inflammatory hypercoagulable phenotype, and is a significant contributor to poor clinical outcomes in COVID-19 patients. Last, we present evidence that targeting platelet P2Y12 represents a promising candidate to reduce proinflammatory platelet-endothelial interactions. Together, these findings demonstrate a previously unappreciated role for platelets and their activation-induced endotheliopathy in COVID-19.This publication has 62 references indexed in Scilit:
- Platelets as Cellular Effectors of Inflammation in Vascular DiseasesCirculation Research, 2013
- Platelet mRNACurrent Opinion in Hematology, 2012
- Platelets and the immune continuumNature Reviews Immunology, 2011
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromesEuropean Heart Journal, 2007
- Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular EventsJournal of the American College of Cardiology, 2006
- Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cellsBlood, 2005
- Platelets: signaling cells in the immune continuumTrends in Immunology, 2004
- Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombinArthritis & Rheumatism, 2004
- S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunityMicroscopy Research and Technique, 2003